When traditional antidepressants fail to lift the heavy veil of depression, science offers a new horizon. For years, the medical community viewed ketamine primarily as an anesthetic. Today, it stands as a pillar of hope for those struggling with treatment-resistant depression (TRD). However, patients and caregivers often find themselves at a crossroads: should they choose Spravato (esketamine nasal spray) or IV ketamine therapy?
Both treatments utilize the power of the ketamine molecule, yet they differ significantly in administration, cost, and clinical regulation. Understanding these nuances helps families make the best choice for their long-term mental wellness.
Introduction to Spravato and IV Ketamine
The landscape of mental health treatment shifted dramatically in 2019 when the FDA approved Spravato, a brand-name esketamine nasal spray. This approval marked the first time a ketamine-based product gained federal recognition specifically for depression.
In contrast, IV ketamine therapy involves the intravenous infusion of “racemic” ketamine. While doctors have used ketamine “off-label” for depression for over two decades, it lacks the specific FDA-approved label for mental health that Spravato carries.
Why the Distinction Matters
- Spravato: This self-administered nasal spray requires medical supervision. It contains only the “S” molecule of ketamine (esketamine), which binds more tightly to specific receptors.
- IV Ketamine: This liquid infusion enters the bloodstream directly. It contains a 50/50 mix of both “R” and “S” molecules, providing a broader chemical profile.
Both options offer a lifeline to those who have tried two or more oral antidepressants without success. At Luma Wellness Center Clinics in San Diego and Temecula, our providers guide patients through this selection process to ensure the treatment aligns with their unique clinical needs.
Mechanism of Action: How They Work in the Brain
Most traditional antidepressants (like SSRIs) target serotonin or norepinephrine. Ketamine and esketamine take a different route. They act as NMDA receptor antagonists.
The Glutamate Revolution
By blocking NMDA receptors, these treatments trigger a surge of glutamate—the brain’s most abundant chemical messenger. This “glutamate burst” stimulates the growth of new synaptic connections. Think of it as “re-wiring” a frozen circuit. This process, known as synaptic plasticity, allows the brain to bypass damaged neural pathways associated with chronic depression.
Esketamine vs. Racemic Ketamine
While both target the NMDA receptor, researchers believe the “S” isomer in Spravato has a higher affinity for the receptor. However, IV ketamine provides 100% bioavailability, meaning the body uses every milligram of the medicine. The nasal spray must pass through the nasal mucosa, where some of the medication naturally dissipates before reaching the bloodstream.
Efficacy Comparison: Clinical Outcomes and Research
When comparing Spravato vs IV ketamine, efficacy remains the top priority for patients. Recent data, including the Harvard 2025 study, provides a clearer picture of how these two treatments perform side-by-side.
Speed of Relief
Clinical studies show that IV ketamine often produces a faster response. Many patients report a “lifting” of mood within hours of their first infusion. Spravato can work faster than oral pills. Most people still need several sessions. Peak benefit often appears after the first two weeks.
Remission Rates
Research indicates that both treatments boast impressive success rates for TRD.
- IV Ketamine: Studies often cite a 60% to 80% response rate for treatment-resistant patients.
- Spravato: Clinical trials showed significant improvement in depressive symptoms compared to a placebo spray plus an oral antidepressant.
According to news.harvard.edu, Real-world data suggests IV ketamine may work more strongly at first. Spravato offers a consistent, regulated option for long-term maintenance and stability.
Safety Profiles and Side Effects
Safety is paramount when dealing with psychoactive substances. Both treatments require a clinical setting; patients must not take these medications at home.
Common Side Effects
Most patients experience side effects during the “active” phase of the treatment (the first 90 to 120 minutes). These include:
- Dissociation: A feeling of detachment from one’s body or environment.
- Dizziness and Nausea: Common but usually manageable with anti-nausea medication.
- Increased Blood Pressure: Both treatments cause a temporary spike in heart rate and blood pressure.
The REMS Program
Because Spravato holds FDA approval, it falls under the Risk Evaluation and Mitigation Strategy (REMS) program. This program mandates that patients remain under observation for at least two hours post-administration. Although IV ketamine has no federal REMS requirement, reputable clinics like Luma Wellness Center use similar safety protocols. Medical professionals provide continuous monitoring throughout treatment.
Read out article Addressing Common Myths About Ketamine Therapy
Administration and Treatment Experience
The delivery of each treatment differs significantly. While both require you to remain in the clinic for safety, the physical experience varies based on the method your doctor uses.
Spravato (Esketamine Nasal Spray)
Patients administer the nasal spray themselves under the direct supervision of a healthcare provider. The medication comes in a standardized dose, typically either 56mg or 84mg. Because the medicine must travel through the nasal tissue, the body only absorbs about 25% to 50% of the drug. A typical session lasts two hours to accommodate the mandatory observation period. Most patients describe a mild to moderate “drifting” feeling that seems less invasive than needle-based procedures.
IV Ketamine Infusion
A medical professional administers IV ketamine through a small catheter in the arm or hand. This method provides 100% bioavailability, meaning your brain receives the full dose instantly and consistently. Doctors tailor these sessions and adjust the dose based on your weight. They also adjust it based on how you respond during the infusion. The active infusion usually lasts about 40 to 60 minutes, followed by a recovery period. Because the medication goes straight into the bloodstream, it works fast. The dissociative effects can feel stronger. They may also feel deeper than with nasal spray.
Also read: What Does Ketamine Treatment Feel Like?
Insurance and Accessibility
Practicality often drives the final decision for many families. Because Spravato holds FDA approval, most insurance plans cover it for treatment-resistant depression. This makes it a sustainable long-term option for patients who need frequent maintenance. Conversely, IV ketamine remains largely an out-of-pocket expense. Some people find the higher cost worthwhile due to faster results and greater precision. Others prefer the nasal spray for its more predictable costs.
Duration of Effects and Maintenance Strategies
Neither treatment is a “one-and-done” cure. Depression is a chronic condition that requires a management plan.
- Induction Phase: Both typically start with a “loading” period (e.g., twice a week for 4 weeks).
- Maintenance Phase: After the initial sessions, the frequency drops. Some patients transition to once every two weeks, while others only need a “booster” every few months.
According toclinicaltrials.gov, the longevity of results depends heavily on the patient’s lifestyle and concurrent therapy. Combining these treatments with traditional talk therapy helps “cement” the new neural pathways.
Patient Experience: Quality of Life
The data tells one story, but patients tell another. Those who choose IV ketamine often describe the experience as “profound” or “transformational.” Because the infusion is steady, the dissociative state feels controlled and smooth.
Spravato patients often appreciate the “medicalized” feel of the nasal spray. It feels less invasive than an IV needle. One patient at Luma Wellness Center said, “The nasal spray felt like a bridge back to myself. It helped without the intensity of a hospital procedure.”
Regardless of your choice, the goal stays the same. You can return to life with family, succeed at work, and feel real joy.
Choosing the Right Treatment: Factors to Consider
How do you decide? Consider these four pillars:
- Clinical Need: If you need the fastest possible intervention, IV ketamine’s 100% absorption might serve you better.
- Budget: If you rely on insurance coverage, Spravato is the logical path.
- Comfort: If you dislike needles, the nasal spray avoids them entirely.
- Customization: IV ketamine allows your doctor to adjust the dose mid-session based on your reaction; Spravato doses are fixed.
Consulting with providers at Luma Wellness Center in San Diego or Temecula allows you to weigh these factors with a medical expert who understands your history.
Conclusion: Summary and Next Steps
Both Spravato and IV ketamine represent the most significant advancement in psychiatry in half a century. Spravato offers an FDA-approved, insurance-friendly nasal spray with a proven track record for TRD. IV ketamine offers a highly potent, customizable infusion that often provides the most rapid relief available today.
The “right” choice depends on your biology, your lifestyle, and your financial situation. You do not have to make this decision alone. At Luma Wellness Center Clinics, we provide comfortable, private environments for both options, ensuring you feel safe and supported.
FAQ
Q1: What is the main difference between Spravato and IV ketamine? Spravato uses esketamine (S-isomer) via a nasal spray and has FDA approval, making insurance coverage likely. IV ketamine uses racemic ketamine (both S and R isomers) delivered via a vein. IV ketamine provides 100% bioavailability, whereas the nasal spray absorbs less efficiently.
Q2: Which treatment works faster: Spravato or IV ketamine? Research suggests IV ketamine often works faster, sometimes after a single infusion. Spravato typically shows significant results after a few sessions. Both work much faster than traditional oral antidepressants.
Q3: Are Spravato and IV ketamine safe to use long term? Yes, when a professional administers them in a clinical setting. Spravato’s REMS program and IV ketamine’s clinical protocols ensure heart rate and blood pressure monitoring. Long-term use requires ongoing medical supervision to prevent misuse and monitor bladder health.
Q4: How do side effects differ between Spravato and IV ketamine? Both cause dissociation and nausea. IV ketamine effects are often more intense but end quickly once the infusion stops. Spravato effects can feel more gradual. Both require a “no driving” rule for the remainder of the treatment day.
Q5: Is one treatment more affordable or covered by insurance? Spravato is generally more affordable because it holds FDA approval and most major insurance providers cover it. IV ketamine is typically an out-of-pocket expense, though some clinics offer financing or superbills for partial reimbursement.
